AXIM BIOTECHNOLOGIES, INC. Debt Conversion, Converted Instrument, Amount
AXIM BIOTECHNOLOGIES, INC. (AXIM) reported Debt Conversion, Converted Instrument, Amount of $380.00 thousand for the 6-month period ending 2024-06-30, per its 10-Q filed 2024-08-19.
Discontinued › Cash Flow › Financing Activities
us-gaap:DebtConversionConvertedInstrumentAmount1 · last filed 2024-08-19
- AXIM BIOTECHNOLOGIES, INC. debt conversion, converted instrument, amount for the quarter ending 2024-06-30 was $0.00.
- AXIM BIOTECHNOLOGIES, INC. debt conversion, converted instrument, amount for the quarter ending 2024-03-31 was $380.00K, a 533.33% increase year-over-year.
- AXIM BIOTECHNOLOGIES, INC. debt conversion, converted instrument, amount for the quarter ending 2023-12-31 was -$20.00K.
- AXIM BIOTECHNOLOGIES, INC. debt conversion, converted instrument, amount for the quarter ending 2023-09-30 was $0.00.
- AXIM BIOTECHNOLOGIES, INC. debt conversion, converted instrument, amount for fiscal 2021 was $0.00.
- AXIM BIOTECHNOLOGIES, INC. debt conversion, converted instrument, amount for fiscal 2017 was $0.00, a 100.00% decline from fiscal 2016.
- AXIM BIOTECHNOLOGIES, INC. debt conversion, converted instrument, amount for fiscal 2016 was $50.00K.
| Period end | Debt Conversion, Converted Instrument, Amount 0 month | Debt Conversion, Converted Instrument, Amount 3 month | Debt Conversion, Converted Instrument, Amount 6 month | Debt Conversion, Converted Instrument, Amount 9 month | Debt Conversion, Converted Instrument, Amount 12 month | Debt Conversion, Converted Instrument, Amount 12 month as first filed |
|---|---|---|---|---|---|---|
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q/A 3 month · filed 2024-08-19 | $380.00K 10-Q · filed 2024-08-19 | $360.00K derived: sum of 3 quarters · filed 2024-08-19 | $360.00K derived: sum of 4 quarters · filed 2024-08-19 | ||
| 2024-03-31 | $380.00K 10-Q/A · filed 2024-05-22 | $360.00K derived: sum of 2 quarters · filed 2024-08-19 | $360.00K derived: sum of 3 quarters · filed 2024-08-19 | $360.00K derived: sum of 4 quarters · filed 2024-08-19 | ||
| 2023-12-31 | -$20.00K derived: 10-Q 12 month − 10-Q 9 month · filed 2024-08-19 | -$20.00K derived: sum of 2 quarters · filed 2024-08-19 | -$20.00K derived: sum of 3 quarters · filed 2024-08-19 | $40.00K 10-Q · filed 2024-08-19 | ||
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-20 | $0.00 derived: sum of 2 quarters · filed 2023-11-20 | $60.00K 10-Q · filed 2023-11-20 | |||
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-21 | $60.00K 10-Q · filed 2023-08-21 | ||||
| 2023-03-31 | $60.00K 10-Q · filed 2023-05-22 | |||||
| 2022-12-31 | $380.00K 10-Q · filed 2024-05-20 | $237.06K 10-K · filed 2023-04-17 | ||||
| 2021-12-31 | $0.00 10-K · filed 2023-04-17 | |||||
| 2021-11-07 | $638.41K 10-K · filed 2023-04-17 | |||||
| 2021-10-12 | $57.47K 10-K · filed 2023-04-17 | |||||
| 2020-03-31 | $518.95K 10-Q/A · filed 2020-07-02 | |||||
| 2019-03-31 | $0.00 10-Q/A · filed 2020-07-02 | |||||
| 2017-12-31 | $0.00 10-K · filed 2018-03-15 | |||||
| 2017-06-30 | $0.00 10-Q · filed 2017-09-14 | |||||
| 2016-12-31 | $50.00K 10-K · filed 2018-03-15 | |||||
| 2016-06-30 | $159.00K 10-Q · filed 2017-09-14 |